Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $7.26 USD
Change Today +0.09 / 1.26%
Volume 435.6K
XNPT On Other Exchanges
As of 8:10 PM 03/30/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Vincent J. Angotti

Chief Operating Officer and Executive Vice President, Xenoport, Inc.
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 1 different industries.

As of Fiscal Year 2013


Mr. Vincent J. Angotti, also known as Vince has been the Chief Operating Officer and Executive Vice President of Xenoport, Inc. since June 4, 2012. Mr. Angotti served as the Chief Commercialization Officer and Senior Vice President of Xenoport, Inc. from May 1, 2008 to June 4, 2012. Mr. Angotti has over 17 years of sales and marketing experience in both large and specialty pharmaceutical businesses. Mr. Angotti served as the Senior Vice President of Sales and Marketing ...

Read Full Background

Corporate Headquarters*

3410 Central Expressway
Santa Clara, California 95051

United States

Phone: 408-616-7200
Fax: --

Board Members Memberships*

There is no Board Members Memberships data available.


Bachelor's Degree
Cornell University
Cornell University
Columbia University

Other Affiliations*

Annual Compensation*

Total Annual Compensation$426,409

Stock Options*

Restricted Stock Awards$264,000
All Other Compensation$5,370
Exercisable Options299,665
Exercisable Options Value$33,781
Unexercisable Options98,335
Unexercisable Options Value$36,719
Total Value of Options$70,500
Total Number of Options398,000

Total Compensation*

Total Annual Cash Compensation$431,779
Total Short Term Compensation$426,409
Other Long Term Compensation$269,370
Total Calculated Compensation$1,130,607
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
XNPT:US $7.26 USD +0.09


Michael S. Anderson Chief Executive Officer and Director
Flamel Technologies SA
Scott Schorer Chief Executive Officer
PlasmaTech Biopharmaceuticals, Inc.
James A. Schoeneck Chief Executive Officer, President and Director
DepoMed Inc.
Peter William Grant Chief Executive Officer and Executive Director
Skyepharma PLC
567.0K GBP
Mark A. Sirgo Pharm.D.Chief Executive Officer, President, Chief Scientific Officer, Executive Director and Member of Executive Subcommittee
BioDelivery Sciences International, Inc.
Compensation as of Fiscal Year --.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact XENOPORT INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at